Streetbeat News

Stock Prices

ORGS

Orgenesis Inc. announced positive results from a real-world study of its ORG-101 CAR-T therapy, showing high complete response rates in both adult and pediatric patients with CD19+ Acute Lymphoblastic Leukemia. The study also indicated a favorable safety profile with low incidence of severe Cytokine Release Syndrome. Harley Street Healthcare Group plans to collaborate with Orgenesis to establish a Global Cancer Initiative to further develop and democratize advanced therapies.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:32 pm

SPY

The US Core PCE Prices for Q2 came in at 2.8%, slightly below the estimated 2.9%. This indicates a marginally lower inflation rate than expected, which could influence market sentiment and investor decisions.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:30 pm

SPY

Retail inventories in the USA, excluding automobiles, increased by 0.5% in July, compared to a 0.3% increase in the previous month.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:30 pm

SPY

The U.S. goods trade balance for July was reported at -$102.66 billion, which is worse than the estimated -$97.7 billion and the prior -$96.56 billion. This indicates a larger trade deficit than expected.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:30 pm

SPY

The GDP for Q2 grew by 3% quarter-over-quarter, surpassing the estimated growth of 2.8%.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:30 pm

IWM

QQQ

SPY

TLT

UUP

The upcoming PCE inflation report, a key indicator for the Federal Reserve, is expected to show a slight increase in inflation rates for July. This report could influence market expectations for a rate cut in September. A higher-than-expected report may boost the U.S. dollar and Treasury yields, while a lower-than-expected report could benefit equities.

Portfolio Pulse from Piero Cingari

August 29, 2024 | 12:28 pm

BBY

Best Buy reported better-than-expected Q2 earnings with an EPS of $1.34 and sales of $9.29 billion, despite a 3% drop in domestic sales. The company raised its FY25 EPS outlook and highlighted growth in tablets and computing. Shares rose 13.60% premarket.

Portfolio Pulse from Anusuya Lahiri

August 29, 2024 | 12:27 pm

AFRM

BCDA

LUCY

BioCardia, Innovative Eyewear, and Affirm see significant stock price increases. BioCardia's rise follows FDA clearance for a new product, Innovative Eyewear benefits from a new sales channel, and Affirm reports strong earnings and guidance.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:24 pm

MRVL

Marvell Technology (NASDAQ:MRVL) is set to release its Q2 earnings, with analysts expecting a slight decrease in EPS compared to last year. The company has a dividend yield of 0.4%, translating to a quarterly dividend of 6 cents per share. To earn $500 monthly from dividends, an investor would need to own 25,000 shares, worth approximately $1.711 million. The stock recently closed at $68.44, down 1.8%.

Portfolio Pulse from Avi Kapoor

August 29, 2024 | 12:22 pm

BBW

Build-A-Bear Workshop (NYSE:BBW) reported a strong Q2 with revenue and EPS beating expectations. Despite a drop in e-commerce demand, the company saw significant growth in franchise revenues and added new locations. BBW maintains its FY24 guidance and expects continued growth in experience locations.

Portfolio Pulse from Lekha Gupta

August 29, 2024 | 12:20 pm